Lilly plans Elanco IPO, posts quarterly profit above estimates

Lilly also said it would not increase its drug prices through the end of the year, following similar moves by Pfizer Inc, Merck & Co Inc and Novartis AG, as the Trump Administration pushes to cut costs for patients. Shares of the company rose as much as 2.6 percent to a near three-year high of $91.20.

from Yahoo News - Latest News & Headlines https://ift.tt/2uKaIke